Camurus Financial Statements From 2010 to 2024

CAMX Stock  SEK 550.50  8.50  1.52%   
Camurus AB financial statements provide useful quarterly and yearly information to potential Camurus AB investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Camurus AB financial statements helps investors assess Camurus AB's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Camurus AB's valuation are summarized below:
Camurus AB does not presently have any fundamental signals for analysis.
Check Camurus AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Camurus AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Camurus financial statements analysis is a perfect complement when working with Camurus AB Valuation or Volatility modules.
  
This module can also supplement various Camurus AB Technical models . Check out the analysis of Camurus AB Correlation against competitors.

Camurus AB Company Operating Margin Analysis

Camurus AB's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Camurus AB Operating Margin

    
  0.03 %  
Most of Camurus AB's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Camurus AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Camurus AB has an Operating Margin of 0.0306%. This is 100.09% lower than that of the Pharmaceuticals sector and 100.03% lower than that of the Health Care industry. The operating margin for all Sweden stocks is 100.56% lower than that of the firm.

Camurus AB Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Camurus AB's current stock value. Our valuation model uses many indicators to compare Camurus AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Camurus AB competition to find correlations between indicators driving Camurus AB's intrinsic value. More Info.
Camurus AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.46  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Camurus AB is roughly  2.17 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Camurus AB's earnings, one of the primary drivers of an investment's value.

About Camurus AB Financial Statements

Camurus AB shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Camurus AB investors may analyze each financial statement separately, they are all interrelated. The changes in Camurus AB's assets and liabilities, for example, are also reflected in the revenues and expenses on on Camurus AB's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Camurus AB , a pharmaceutical company, develops and commercializes pharmaceuticals for serious and chronic conditions in Europe, Australia, the United States, Japan, and internationally. The company was founded in 1991 and is headquartered in Lund, Sweden. Camurus AB operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 140 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Camurus Stock Analysis

When running Camurus AB's price analysis, check to measure Camurus AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Camurus AB is operating at the current time. Most of Camurus AB's value examination focuses on studying past and present price action to predict the probability of Camurus AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Camurus AB's price. Additionally, you may evaluate how the addition of Camurus AB to your portfolios can decrease your overall portfolio volatility.